LACERTA THERAPEUTICS
Lacerta Therapeutics is a clinical stage gene therapy company using a constellation of proprietary adeno-associated virus (AAV) vector technologies to develop treatments for central nervous system and lysosomal storage diseases. With unmatched scientific expertise and depth in the development, production, and application of AAV vectors, Lacerta Therapeutics is advancing its clinical programs using its proprietary capsid variants and scalable vector manufacturing platform. The experience and acco... mplishments of the Lacerta Therapeutics founders are unsurpassed in AAV gene therapy. In addition to world-class basic AAV vector development and gene therapy clinical trial expertise, our team brings to bear individuals with novel insight into developing novel, targeted neurological and lysosomal storage disease treatments.
LACERTA THERAPEUTICS
Industry:
Biotechnology Genetics Therapeutics
Founded:
2017-01-01
Address:
Alachua, Florida, United States
Country:
United States
Website Url:
http://www.lacertatherapeutics.com
Total Employee:
1+
Status:
Active
Total Funding:
30 M USD
Technology used in webpage:
SPF Mobile Non Scaleable Content Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS GoDaddy DNS CPanel SSL AWS Global Accelerator
Similar Organizations
Calimmune
Calimmune is a clinical-stage gene therapy company.
Cerebral Therapeutics
Cerebral Therapeutics is a clinical-stage pharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
LogicBio Therapeutics
LogicBio develops gene therapy vectors for previously incurable genetic and infectious diseases.
Current Employees Featured
Sergei Zolotukhin Co-Founder @ Lacerta Therapeutics
Co-Founder
Edgar Rodriguez-Lebron Co-Founder, President, and Chief Executive Officer @ Lacerta Therapeutics
Co-Founder, President, and Chief Executive Officer
2016-08-01
Nicholas Muzyczka Co-Founder @ Lacerta Therapeutics
Co-Founder
Arun Srivastava Co-Founder @ Lacerta Therapeutics
Co-Founder
Kenneth Warrington Co-Founder, Scientific Advisor, and Chief Technology Officer @ Lacerta Therapeutics
Co-Founder, Scientific Advisor, and Chief Technology Officer
2017-11-01
Todd E. Golde Co-Founder @ Lacerta Therapeutics
Co-Founder
Coy Heldermon Co-Founder @ Lacerta Therapeutics
Co-Founder
Darin Falk Chief Scientific Officer @ Lacerta Therapeutics
Chief Scientific Officer
2021-11-01
Ronald Mandel Co-Founder @ Lacerta Therapeutics
Co-Founder
Founder
Investors List
Sarepta Therapeutics
Sarepta Therapeutics investment in Venture Round - Lacerta Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-03-01 | Lacerta Therapeutics Expands Executive Leadership Team |
Official Site Inspections
http://www.lacertatherapeutics.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Lacerta Therapeutics"
Lacerta Therapeutics - Crunchbase Company Profile & Funding
Lacerta Therapeutics is a clinical stage gene therapy company using a constellation of proprietary adeno-associated virus (AAV) vector technologies to develop treatments for central nervous …See details»
About | Lacerta Therapeutics
Lacerta Therapeutics is dedicated to the discovery and development of AAV-based gene therapies. We aim to provide novel therapeutic options by leveraging our expertise in the …See details»
Lacerta Therapeutics | Transformative Science for …
Sep 25, 2022 · Lacerta Therapeutics is dedicated to the discovery and development of AAV-based gene therapies. We aim to provide novel therapeutic options by leveraging our expertise in the nervous system, proprietary AAV …See details»
Lacerta and Prevail, A Wholly Owned Subsidiary of Lilly, …
Aug 23, 2022 · Lacerta Therapeutics is a fully-integrated gene therapy company that is focused on leveraging its proprietary capsid technology and scalable manufacturing platforms to advance adeno-associated...See details»
Lacerta Therapeutics, Inc. - Drug pipelines, Patents ... - Patsnap
Lacerta Therapeutics is a clinical stage company that specializes in gene therapy for central nervous system and lysosomal storage diseases.See details»
Lacerta Therapeutics Company Profile 2024: Valuation, …
Developer of gene therapeutics designed to develop treatments for the central nervous system and lysosomal storage diseases.See details»
Lacerta Therapeutics - LinkedIn
Clinical stage gene therapy company using a constellation of proprietary AAV vector technologies to develop novel treatments for central nervous system and lysosomal storage diseases. Lacerta...See details»
Lacerta | VentureRadar
Lacerta Therapeutics is a clinical stage gene therapy company using a constellation of proprietary adeno-associated virus (AAV) vector technologies to develop treatments for central nervous …See details»
Lacerta Therapeutics - Craft
Lacerta Therapeutics is focused on CNS-targeted treatments and lysosomal storage diseases. It is a clinical stage gene therapy company using a constellation of proprietary adeno-associated …See details»
Lacerta Therapeutics - Contacts, Employees, Board Members, …
Lacerta Therapeutics has 9 current employee profiles, including Co-Founder Sergei Zolotukhin. Lacerta Therapeutics is a clinical stage gene therapy company.See details»
Lacerta Therapeutics Signs Gene Therapy Research Partnership …
Nov 12, 2020 · Lacerta Therapeutics is a clinical-stage gene therapy company leveraging its proprietary adeno-associated virus (AAV) vector technology and manufacturing platforms to …See details»
Lacerta Therapeutics - Biotech Careers
Lacerta Therapeutics is dedicated to the discovery and development of AAV-based gene therapies. They aim to provide novel therapeutic options by leveraging our expertise in the …See details»
Lacerta Therapeutics Strengthens Its Position in the AAV Gene …
Nov 10, 2020 · Lacerta Therapeutics is a clinical-stage gene therapy company leveraging its proprietary adeno-associated virus (AAV) vector technology and manufacturing platforms to …See details»
Lacerta Therapeutics Expands Executive Leadership Team
Mar 1, 2022 · Lacerta Therapeutics, Inc. is focused on exploiting our proprietary capsid technology and scalable manufacturing platform to advance AAV-based therapies via three …See details»
Lacerta Therapeutics Appoints Min Wang, PhD, JD and Marc Wolff …
Nov 24, 2021 · Lacerta Therapeutics, Inc. is focused on exploiting our proprietary capsid technology and scalable manufacturing platform to advance AAV-based therapies via three …See details»
Lacerta Therapeutics Strengthens Its Position in the AAV Gene …
Nov 10, 2020 · UF startup and UF Innovate | Sid Martin Biotech alum Lacerta Therapeutics, a clinical-stage gene therapy company, announced new leadership. Dr. Edgar Rodriguez …See details»
Lacerta Therapeutics Signs Gene Therapy Research Partnership …
Nov 12, 2020 · Lacerta Therapeutics, Inc (www.lacertatx.com) is a clinical-stage gene therapy company that is leveraging its proprietary adeno-associated virus (AAV) vector technology and …See details»
Lacerta Therapeutics Signs Gene Therapy Research ... - UF Innovate
Nov 13, 2020 · Lacerta Therapeutics Signs Gene Therapy Research Partnership With UCB website builders UF startup and UF Innovate | Sid Martin Biotech alum Lacerta Therapeutics , …See details»
Sarepta further expands in gene therapy with $30M Lacerta deal
Aug 9, 2018 · Sarepta Therapeutics reached a licensing deal with Lacerta Therapeutics for three gene therapy programs, expanding its pipeline to include 11 such programs, the company …See details»
Sarepta builds in gene therapy with $30M Lacerta deal
Aug 9, 2018 · The tie-up with Lacerta follows an alliance with Myonexus for five gene therapy programs focusing on limb girdle muscular dystrophy (LGMD), plus earlier collaborations with …See details»